Clinical trials on trial
By Osagie Obasogie,
The New Scientist
| 01. 22. 2011
[Commentary]
A great deal of scientific research – especially in medicine – relies on human subjects. Protecting volunteers has been a prominent social and legal issue since the 1950s, when the world recoiled from the horrors of Nazi medicine.
We have come a long way since then, but it pays to remember that the Nazis did not have a monopoly on atrocities committed in the name of science. One of the worst cases of human subject abuse was perpetrated by American scientists who, between 1932 and 1972, misled hundreds of black people with syphilis in Tuskegee, Alabama, by deliberately leaving them untreated to enable researchers to study the progression of the disease.
To view the entire article, please click below for version in PDF format.
Related Articles
By Editorial Staff, The Guardian | 07.05.2026
Ever since Crispr-Cas9 gene-editing technology emerged in the early 2010s, ethical questions around genetically altered humans, so-called designer babies, have become increasingly urgent. There is already a worldwide legal prohibition. No country currently allows human germline editing (meaning genetic changes...
By Anna Louie Sussman, The New York Times | 07.01.2026
Birthrates in much of the developed world are at record lows, but there’s one demographic group that’s exploring new frontiers of fertility: ultrawealthy men. Deploying nearly limitless resources, a small number of them are reproducing at such an extraordinary scale...
By Robert P. Baird, The Guardian | 06.30.2026
In 2017, a 33-year-old political philosopher named Iason Gabriel was told by a friend that he ought to apply for a job at DeepMind, the London-based subsidiary of Google where much of its AI research was concentrated. The suggestion was not...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
